Brief: Carsgen Therapeutics Holdings Says CT041 Achieved IND Clearance From NMPA
20/04/2023 04:28
April 20 (Reuters) - CARsgen Therapeutics Holdings Ltd
2171.HK :
* CT041 ACHIEVED IND CLEARANCE FROM NMPA
Further company coverage: 2171.HK
((reuters.briefs@thomsonreuters.com;))
Recent news on CARsgen Therapeutics Holdings
See all newsBrief: Carsgen Therapeutics Says CT1190B Receives IND Clearance From NMPA For Relapsed/Refractory Large B-Cell Lymphoma
Brief: Carsgen Therapeutics Says CT0596 Receives IND Clearance From NMPA
Brief: Carsgen Therapeutics Approves Share Repurchase Plan For Up To 30.12 Million Shares
CARsgen Therapeutics climbs on board nod for share buyback
Brief: Carsgen Therapeutics Says NMPA Approves Satricabtagene Autoleucel For Advanced Gastric Cancer